[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100508739":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":27,"centralContacts":31,"locations":37,"responsibleParty":58,"collaborators":61,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":18,"eligibilityCriteria":69,"healthyVolunteers":65,"sex":70,"minAge":71,"maxAge":72,"enrollmentInfo":73,"targetDuration":18,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":83,"overallStatus":40,"whyStopped":18,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"National Taipei University of Nursing and Health Sciences","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Test Group","EXPERIMENTAL","The percutaneous nerve discharger (model GM350PP) of APEX low-frequency therapeutic device is used for transcutaneous electrical nerve stimulation of acupoints. The approved number of medical equipment license for this product is: Department of Health Medical Device No. 006696, and the use mode of intervention measures is P5 Disperse -Dense Modulation mode (discharge frequency 2Hz\u002Fwave width 260μs\u002Fduration 3sec and discharge frequency 100 Hz\u002Fwavewidth 140μs\u002Fcontinuation 3sec alternately, maximum discharge volume 80mA), stimulate Neiguan (PC6), Hegu (LI4), Sanyinjiao (SP6) and Taichong (LR3) points, twice a day, 30 minutes each time, for 4 weeks, the intensity is divided into 10-25 mA for hands and 25-40 mA for feet, depending on personal tolerance Adjust flexibly within the interval, and evaluate the severity of neuropathy symptoms of the test every week.",[13],"Device: Transcutaneous Electrical Nerve Stimulation",{"label":15,"type":16,"description":17,"interventionNames":18},"Control Group","NO_INTERVENTION","4 weeks of usual care, including prescribe vitamin B6 or B12 and massage therapy. Assessing the severity of neuropathy symptoms every week.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","Transcutaneous Electrical Nerve Stimulation","Transcutaneous Electrical Nerve Stimulation (TENS) uses machines to generate electric current, flows through the skin and conducts to the nerves, triggers a chain reaction of nerves through a new stimulus source, and achieves the effect of pain relief. Using different frequencies and intensities will Produce different effects and trigger different physiological mechanisms.",[9],[26],"Transcutaneous Electrical Acupoint Stimulation",[28],{"name":29,"affiliation":5,"role":30},"WANG, PHD","PRINCIPAL_INVESTIGATOR",[32],{"name":33,"role":34,"phone":35,"phoneExt":18,"email":36},"CHIA HAO YANG","CONTACT","+886912631133","henry1993110101@gmail.com",[38],{"facility":39,"status":40,"city":41,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"Changhua Christian Hospital","RECRUITING","Changhua","500","Taiwan","TW",{"type":46,"coordinates":47},"Point",[48,49],120.5512,24.0692,{"lat":49,"lon":48},[52,53,57],{"name":33,"role":34,"phone":35,"phoneExt":18,"email":36},{"name":54,"role":34,"phone":55,"phoneExt":18,"email":56},"Hsiu Ying HSU, Master","+886965066390","14651@cch.org.tw",{"name":54,"role":34,"phone":18,"phoneExt":18,"email":18},{"type":30,"investigatorFullName":59,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Tsae Jyy, Wang","RN PhD Professor",[62],{"name":39,"class":6},"100508739","transcutaneous-electrical-acupoint-stimulation-on-symptoms-associated-with-chemotherapy-induced-peripheral-neuropathy-100508739",false,"NCT05904340","Transcutaneous Electrical Acupoint Stimulation on Symptoms Associated with Chemotherapy Induced Peripheral Neuropathy","The Efficacy of Social Media Assisted Home-based Transcutaneous Electrical Acupoint Stimulation on Symptoms Associated with Chemotherapy Induced Peripheral Neuropathy in Patients with Breast Cancer","Inclusion Criteria:\n\n1. Primary diagnosed with breast cancer for the first time by a physician.\n2. Patients who have completed chemotherapy or postoperative adjuvant chemotherapy within 3 months, and the chemotherapy drugs used are paclitaxel, vinblastine or platinum drugs.\n3. Patients who have been evaluated by doctors as peripheral neuropathy caused by chemotherapy, and whose symptoms persist after completing chemotherapy.\n4. Peripheral sensory or peripheral motor neuropathy grade ≥ 2 in general toxicity criteria (NCI-CTCAE).\n5. Those who have clear consciousness and can communicate in Mandarin or Taiwanese.\n\nExclusion Criteria:\n\n1. Patients suffering from carcinoma in situ.\n2. Patients suffering from stage IV cancer.\n3. Patients suffering from metastatic cancer.\n4. Patients receiving peripheral neuropathy drugs (Duloxetine)\n5. Patients receiving acupoint stimulation therapy.\n6. Patients who are allergic to silicone patches.\n7. Patients with cardiac pacemakers.\n8. Patients suffering from diabetic peripheral neuropathy.\n9. Patients suffering from peripheral neuropathy of acquired immunodeficiency syndrome.\n10. Patients receiving treatment for mental illness.","ALL","18 Years","80 Years",{"count":74,"type":75},86,"ESTIMATED","INTERVENTIONAL",[78],"NA","Breast cancer ranks first in Taiwan's top ten gynecological cancers. Chemotherapy is a standard treatment method for colorectal cancer and breast cancer, but while destroying cancer cells, it also destroys healthy cells, resulting in side effects. Peripheral neuropathy can lead to peripheral nerve damage and decreased activity, which affects the patient's quality of life. Currently, there is no standard and effective method for treating peripheral neuropathy caused by chemotherapy. Therefore, the purpose of this study is to investigate the effect of percutaneous electrical acupoint stimulation on improving peripheral nerve symptoms in breast cancer patients undergoing chemotherapy.",[81,82],"Breast Neoplasms","Chemotherapy-induced Peripheral Neuropathy",[84,85,22,26],"Breast Cancer","Chemotherapy-Induced Peripheral Neuropathy","2024-11-04",{"date":88,"type":89},"2024-11-06","ACTUAL",{"date":91,"type":89},"2023-07-01",{"date":93,"type":75},"2025-04-30",{"name":5,"class":6},1]